Premium
Hot Features
Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.
| Date | Nom du détenteur | Actions transigées | Fourchette de valeur ($) | Type d'opération | Fourchette de prix ($) | Actions en fin de déclaration | % de variation |
|---|---|---|---|---|---|---|---|
| 2026-04-28 | Mr. Laurence Douglas FinkFounder, CEO & Chairman | -33,90k | 35,61M | Vente | 1,05k | 230,52k | -12,82% |
| 2026-04-27 | Mr. Robert Steven KapitoPresident & Member of Board of Directors | -8,74k | 9,23M | Vente | 1,06k | 200,29k | -4,18% |
| 2026-02-24 | Mr. Rich KushelSenior MD & Head of the Portfolio Management Group | -2,39k | 2,58M | Vente | 1,08k | 136,32k | -1,72% |
| 2026-02-23 | Mr. Stephen CohenSenior MD, Chief Product Officer & Head of Global Product Solutions | -225,00 | 240,65k | Vente | 1,07k | 2,00k | -10,10% |
| 2026-02-19 | Mr. Stephen CohenSenior MD, Chief Product Officer & Head of Global Product Solutions | -657,00 | 0,00 | Other Disposition | - | 2,23k | -22,77% |
| 2026-02-13 | Mr. Robert Lawrence GoldsteinSenior MD & COO | -8,63k | 0,00 | Other Disposition | - | 47,80k | -15,30% |
| 2026-02-11 | Mr. Stephen CohenSenior MD, Chief Product Officer & Head of Global Product Solutions | -2,18k | 2,34M | Vente | 1,07k | 2,89k | -43,03% |
| 2026-02-10 | Mr. Robert Lawrence GoldsteinSenior MD & COO | -54,19k | 31,09M | Derivative Exercise and Sale | 513,50 - 1,09k | 47,80k | - |
| 2026-02-11 | Mr. Robert Lawrence GoldsteinSenior MD & COO | -5,29k | 5,74M | Vente | 1,08k - 1,09k | 47,80k | -9,97% |
| 2026-02-04 | Ms. Margaret L. JohnsonIndependent Member of Board of Directors | -419,00 | 0,00 | Other Disposition | - | 3,01k | -12,23% |
| 2026-01-30 | Mr. Marc David ComercheroMD & CAO | -558,00 | 624,37k | Sale to Issuer | 1,12k | 2,83k | -16,47% |
| 2026-01-30 | Ms. Caroline HellerSenior MD & Global Head of HR | -740,00 | 828,02k | Sale to Issuer | 1,12k | 1,90k | -28,08% |
| 2026-01-30 | Mr. Christopher Joseph MeadeGeneral Counsel & Chief Legal Officer | -3,48k | 3,89M | Sale to Issuer | 1,12k | 10,00k | -25,79% |
| 2026-01-30 | Ms. Rachel LordSenior MD & Head of International | -2,79k | 3,12M | Sale to Issuer | 1,12k | 9,29k | -23,08% |
| 2026-01-30 | Mr. Stephen CohenSenior MD, Chief Product Officer & Head of Global Product Solutions | -2,14k | 2,39M | Sale to Issuer | 1,12k | 5,06k | -29,66% |
| 2026-01-30 | Mr. Martin S. SmallSenior MD, CFO & Global Head of Corporate Strategy | -3,76k | 4,20M | Sale to Issuer | 1,12k | 5,48k | -40,65% |
| 2026-01-30 | Mr. Rich KushelSenior MD & Head of the Portfolio Management Group | -4,19k | 4,68M | Sale to Issuer | 1,12k | 138,71k | -2,93% |
| 2026-01-30 | Mr. Robert Lawrence GoldsteinSenior MD & COO | -6,55k | 7,33M | Sale to Issuer | 1,12k | 53,10k | -10,99% |
| 2026-01-30 | Mr. Robert Steven KapitoPresident & Member of Board of Directors | -10,82k | 12,10M | Sale to Issuer | 1,12k | 209,03k | -4,92% |
| 2026-01-30 | Mr. Laurence Douglas FinkFounder, CEO & Chairman | -14,40k | 16,11M | Sale to Issuer | 1,12k | 264,42k | -5,17% |
| 2026-01-21 | Mr. Rich KushelSenior MD & Head of the Portfolio Management Group | -20,00k | 12,23M | Derivative Exercise and Sale | 513,50 - 1,13k | 134,70k | - |
| 2026-01-16 | Mr. Martin S. SmallSenior MD, CFO & Global Head of Corporate Strategy | -27,05k | 17,79M | Derivative Exercise and Sale | 513,50 - 1,17k | 2,45k | - |
| 2025-12-02 | Mr. Adebayo O. OgunlesiChairman & CEO Global Infrastructure Partners, Senior MD & Member of Board of Director | -28,55k | 0,00 | Other Disposition | - | 1,79M | -1,57% |
| 2025-12-01 | Mr. Martin S. SmallSenior MD, CFO & Global Head of Corporate Strategy | -1,26k | 1,31M | Vente | 1,04k | 2,45k | -33,95% |
| 2025-11-13 | Mr. Robert Steven KapitoPresident & Member of Board of Directors | -1 000,00 | 0,00 | Other Disposition | - | 200,29k | -0,50% |
| 2025-10-20 | Ms. Rachel LordSenior MD & Head of International | -12,00k | 13,98M | Vente | 1,16k - 1,17k | 4,64k | -72,14% |
| 2025-07-30 | Mr. Rich KushelSenior MD & Head of the Portfolio Management Group | -17,14k | 10,41M | Derivative Exercise and Sale | 513,50 - 1,12k | 136,41k | - |
| 2025-07-25 | Ms. Rachel LordSenior MD & Head of International | -18,04k | 11,04M | Derivative Exercise and Sale | 513,50 - 1,13k | 16,64k | - |
| 2025-07-24 | Mr. Laurence Douglas FinkFounder, CEO & Chairman | -26,88k | 30,21M | Vente | 1,12k - 1,13k | 251,70k | -9,65% |
| 2025-07-24 | Mr. Fabrizio FredaIndependent Member of Board of Directors | -4,43k | 4,98M | Vente | 1,12k | 2,63k | -62,74% |
| 2025-07-24 | Ms. Susan Lynne WagnerIndependent Member of Board of Directors | -90,00 | 0,00 | Other Disposition | - | 426,88k | -0,02% |
| 2025-07-17 | Mr. Laurence Douglas FinkFounder, CEO & Chairman | -7,62k | 0,00 | Other Disposition | - | 278,58k | -2,66% |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
S'inscrire avec l'e-mail
Vous avez déjà un compte? Connexion
Vous n'avez pas de compte ? Inscription
En m'inscrivant, je confirme avoir lu, compris et accepté les Conditions générales d'ADVFN et j'affirme etre un investisseur privé.
